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Necks Too Large for Standard EVAR
Michael Wildermana, Gregory Simoniana, Michael Curib, David
O’Connora, Massimo Napolitanoa. aHackensack University Medical
Center, Hackensack, NJ; bUniversity of Medicine and Dentistry of New
Jersey, Newark, NJ
Objectives: To evaluate early outcomes and short-term durability of
thoracic stent cuffs in patients with abdominal aortic aneurysms (AAA)
and infrarenal necks too large for standard endovascular aneurysm repair
(EVAR) who were symptomatic, not suitable for open surgery, and could
not wait for a custom fenestrated device to be created.
Methods: From July 2010 to December 2012, 13 patients with juxta-
or pararenal AAA underwent endovascular repair with thoracic aortic
endografts as proximal aortic cuffs in conjunction with standard EVAR
devices. The patients were symptomatic and were deemed unﬁt for open
surgery due to severe cardiopulmonary and/or renal comorbidities. All
patients had infrarenal neck diameters greater than the indications for use
for standard aortic endografts. Primary end points were technical success
(as deﬁned by aneurysm exclusion without endoleak), follow-up aneurysm
exclusion by computed tomographic angiogram, and 30-day and long-
term mortality.
Results: Thirteen patients (10 men, 3 women) with a mean age of
77.1 years underwent EVAR who presented with symptomatic juxta- or
pararenal abdominal aortic aneurysms. The mean aneurysm size was 7.2
cm, and the mean infrarenal aortic neck diameter was 35.5 mm
measured by centerline analysis. Technical success was achieved in
100% of cases. The 30-day mortality was 8% (one of 13 patients). At
a mean follow-up of 524 days, there have been no endoleaks or other
aneurysm related mortalities. There was one death due to stroke at
605 days postop.
Conclusions: Complex endovascular repair of juxta and pararenal
AAA using thoracic stents cuffs can be safely and successfully performed
in symptomatic patients medically unﬁt for open repair. Using thoracic stent
cuffs below the visceral vessels may reduce the complexity and possibly the
risk of repair when compared with fenestrated endografts. These techniques
can be used for urgent and emergent cases where the wait time for fenes-
trated technology is prohibitive. Although our results have demonstrated
short-term success, long-term durability of this technique with further eval-
uation is required.
Clinical Impact of Isolated Infrarenal Aortic Stenosis
Rafael D. Malgora, Nicos Labropoulosa, Marc Borgeb, Celso Diasc, Peter
Pappasd, Apostolos Tassiopoulosa. aStony Brook University Medical
Center, Stony Brook, NY; bLoyola University Medical Center, Chicago,
Ill; cThe Aroostok Medical Center, St. Presque Isle, Me; dThe Brooklyn
Hospital Center, New York, NY
Objectives: To evaluate the clinical characteristics and treatment
outcomes in patients with isolated infrarenal aortic stenosis
Methods: Consecutive patients with isolated infrarenal aortic
stenosis who presented with claudication or lower extremity distal
embolization were included. Patients with concomitant disease in the
iliac and lower extremity arteries and those with less than 2-year
follow-up were excluded. Clinical presentation, risk factors, and endo-
vascular treatment were recorded. Clinical evaluation, duplex ultra-
sound, and ankle-brachial index were performed at 1, 6, 12 months,
and annually thereafter.
Results: There were 51 patients with aortic stenosis of whom 34
did not fulﬁll the inclusion criteria leaving 17 for analysis. These wereTable. Patency rates, limb salvage, survival, and amputation-free survival in AA
PP 12/36 months SP 12/36 months
AA(n ¼ 108) 77 6 4%/70 6 5% 90 6 1%/84 6 2%
CAU (n ¼ 730) 78 6 2%/68 6 2% 90 6 3%/84 6 4%
P .845 .736
AA endo (n ¼ 97) 78 6 5%/71 6 6% 89 6 4%/84 6 5%
CAU endo (n ¼ 696) 80 6 2%/66 6 2% 89 6 1%/84 6 2%
P .427 .775
AA open (n ¼ 31) 75 6 8%/68 6 10% 90 6 6%/83 6 8%
CAU open (n ¼ 196) 80 6 3%/69 6 4% 87 6 3%/80 6 4%
P .450 .748all females, mean age 44 years, range 37-49. All but one patient had
three or more risk factors. Fifteen patients had claudication and seven
presented with distal embolization. The lesion length was 4 cm in two
patients. Seven patients underwent transluminal balloon angioplasty,
ﬁve had angioplasty followed by stenting, and ﬁve had primary stenting.
Procedural complications developed in three patients at the access site.
After intervention, the pressure gradient across the stenotic area was
signiﬁcantly improved in all patients (49 6 11.6 mm Hg vs 6.3 6 2
mm Hg; P < .001). Postoperative ankle-brachial index was improved
in all patients (mean preoperative 0.66 6 0.07 vs postoperative 0.92
6 0.06; P < .001). The mean follow-up was 3.7 years, range 2-7.
Two patients required reintervention with balloon angioplasty at 4 and
5 years and a third one angioplasty plus stenting at 3 years. None of
the 17 patients developed life style limiting claudication or distal
embolization.
Conclusions: Symptomatic isolated infrarenal aortic stenosis is rare
but may be found in young females who have at least three cardiovascular
risk factors present. Balloon angioplasty alone or angioplasty plus stenting
are effective treatments with high success and low complication rates in
this cohort of patients
Similar Outcomes in African American Compared with Caucasian Men
with Chronic Limb Ischemia in an Equal Access to Care Setting
Hasan H. Dosluoglua, Raphael Blochleb, Linda M. Harrisb, Maciej L.
Dryjskib. aVA Western NY Healthcare System, SUNY at Buffalo, Buffalo,
NY; bSUNY at Buffalo, Buffalo, NY
Objectives: African Americans (AA) with symptomatic peripheral
arterial disease (PAD) have been reported to have less revascularization
attempts and poorer patency and limb salvage rates. The goal of this study
is compare the outcomes in AA and Caucasian (CAU) men with chronic
limb ischemia in a setting with equal access to care.
Methods: All AA and CAU men who were treated for symptomatic
PAD between November 2003 and June 2012 were included.
Results: Of the 838 men (1072 limbs), 108 were AA (139
limbs) and 730 were CAU (933 limbs). AA were more likely to
have insulin dependent diabetes mellitus (IDDM), hypertension, dial-
ysis-dependence, lower albumin levels, and critical limb ischemia
(CLI) (73% vs 61%, P ¼ .006) whereas CAU had more coronary
artery disease, dyslipidemia, chronic obstructive pulmonary disease,
and were older. Type of revascularization, and primary amputation
rates (9% vs 7%; P ¼ .4) were similar between groups. Infrapopliteal
interventions were more frequent in AA (47% vs 28%; P < .001).
Perioperative morbidity and mortality were similar. Patency rates,
limb salvage, and survival were similar in AA and CAU who under-
went open, or endovascular revascularization (mean follow-up, 31.5
months) (Table). IDDM, gangrene, poor functional capacity, and
dialysis-dependence independently predicted limb loss in multivariate
analysis, whereas race did not.
Conclusions: In an equal access to care setting, similar outcomes can
be achieved in AA men with symptomatic PAD, despite poorer functional
status, higher rates of dialysis-dependence, IDDM, and more frequent infra-
popliteal interventions.
Is Intramural Thrombus Protective and/or Predictive of Type II
Endoleak in Patients Undergoing EVAR?
Sam Tyagi, Shinichi Fukuhara, Stephen Haveson. Beth Israel Medical
Center, New York, NYand CAU groups
LS 12/36 months Survival 12/36 months AFS
84 6 4%/79 6 5% 80 6 3%/67 6 4% 66 6 5%/56 6 5%
90 6 1%/86 6 2% 80 6 1%/64 6 2% 66 6 2%/46 6 2%
.078 .865 .412
84 6 5%/77 6 6% 79 6 4%/65 6 5% 62 6 6%/51 6 6%
90 6 2%/86 6 2% 82 6 2%/64 6 2% 66 6 2%/45 6 3%
.066 .561 .660
84 6 9%/84 6 9% 87 6 6%/80 6 9% 79 6 9%/69 6 12%
92 6 3%/85 6 4% 81 6 3%/70 6 4% 68 6 4%/52 6 5%
.705 .504 .269
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ence and anatomy of intramural thrombus in infrarenal abdominal aortic
aneurysms and correlate these ﬁndings with type II endoleaks and the asso-
ciated vessels after endovascular aneurysm repair (EVAR).
Methods: This study included 90 patients that underwent EVAR at
our institution from January 2006 to February 2012 for abdominal aortic
aneurysm. All patients had pre- and postoperative contrast computed
tomography (CT) and/or dedicated abdominal U/S at 1, 6, and 12
months. All patients without the described CT, U/S, and follow-up were
excluded. Preoperative CTs were reviewed for coverage of IMA and lumbar
artery origins with thrombus. Follow-up CT and U/S were reviewed and
presence and culprit vessel of type II endoleak was noted.
Results: A total 15 of 90 patients had type II endoleaks (16.7%). Five
endoleaks were identiﬁed in the 15 patients without intramural thrombus;
whereas 15 endoleaks were found in the 75 patients with intramural
thrombus (33.3.% vs 13.3%; P ¼ .058). Two patients had endoleaks
involving more than one vessel. The presence of intramural thrombus was
found to be protective for right lumbar type II endoleaks (0% vs 13%; P
¼ .027), and the same observation was found in left lumbar type II endo-
leaks (0% vs 10%, P ¼ .040). Intramural thrombus obstructing the IMA
oriﬁce trended toward protection but was not statistically signiﬁcant (5%
vs 13.3%; P ¼ .21) (Table).
Conclusions: Our ﬁndings suggest that intramural thrombus
protects against type II endoleak. Understanding the anatomy of the
thrombus and aneurysm sac can identify patients at increased risk for
type II endoleak. These patients may beneﬁt from aneurysm sealing with
new endovascular products such as polymer, ﬁbrin, or endobags at the
time of endografting.Table. Results
IMA thrombus (n ¼ 60) No thrombus (n ¼ 30)
IMA type II
endoleak
3 (5%) 4 (13.3%) P ¼ .21
RL thrombus (n ¼ 43) No thrombus (n ¼ 47)
RL type II
endoleak
0 (0%) 6 (13%) P ¼ .027
LL Thrombus (n ¼ 49) No thrombus (n ¼ 37)
LL type II
endoleak
0 (0%) 4 (10%) P ¼ .040
*Use of Drug Eluting Coronary Stents for Infrageniculate Lesions in
High Risk Patients with Critical Limb Ischemia: Intermediate
Follow-Up Demonstrates Favorable Outcomes
Michael Wilderman, Gregory Simonian, David O’Connor, Massimo
Napolitano. Hackensack University Medical Center, Hackensack, NJ
Objectives: Patients with critical limb ischemia pose a signiﬁcant ther-
apeutic challenge due to high rates of associated comorbidities and increased
risk of limb loss. We evaluated the role of drug eluting stents in below the
knee revascularizations in patients with critical limb ischemia who are
deemed high-risk candidates for open revascularization procedure.
Methods: A retrospective review of 24 high-risk patients (18males and
6 females) underwent drug eluting stent placement over a period of 24
months (26 limbs, 30 lesions). The mean age was 78.5 6 9.2 years. Patient
comorbidities included hypertension (90%), diabetes (65%), coronary artery
disease (60%), smoking (50%), chronic renal insufﬁciency (50%), and hyper-
lipidemia (75%). The mean American Society of Anesthesiologists class was
3.56 0.7 and the Rutherford category of the lesions was 4.96 0.8. In addi-
tion, 36% of patients had cellulitis present. Standard percutaneous techniques
were used for stent placement. Outcomes were measured in terms of wound
healing, limb salvage, relief of symptoms, and stent patency.
Results: The lesions included 3 below knee popliteal, 5 tibioperoneal
trunk, 4 anterior tibial, 4 peroneal, 8 posterior tibial, and 6 distal anasto-
motic stenoses. Simultaneous proximal interventions were performed
during 32% of the procedures. Median stent diameter was 3.0 6 0.5 mm.
Median follow-up was 20 months (11-1037 days). Five patients died of
causes unrelated to the procedure. Of the remaining patients, pain relief
was observed in 82%, amputation free rate was 83%, and wounds healed
in 75% of patients. In addition, duplex ultrasound at follow-up showedthe patency of the stents to be 85%. Three patients had minor complications
(two hematomas and one puncture site pseudo aneurysm).
Conclusions: Intermediate term follow-up demonstrates that the use
infrageniculate drug eluting stents is a safe and effective method for treat-
ment of critical limb ischemia in high-risk surgical patients. Further studies
to determine long-term follow-up are warranted.
Scientifc Session IV: Aortic I
Accuracy and Utility of Intravascular Ultrasound for Fenestrated
Endovascular Aortic Aneurysm Repair
Martyn Knowles, Gregory A. Stanley, Mirza S. Baig, Rawson J. Valentine,
Carlos H. Timaran. UT Southwestern, Dallas, Tex
Objectives: Intravascular ultrasound (IVUS) is frequently used to
determine neck measurements and location of renal arteries for endovascu-
lar aortic aneurysm repair (EVAR), however, its utility for fenestrated endo-
vascular aneurysm repair (FEVAR) has not been addressed. The purpose of
this study was to assess the utility and accuracy of IVUS to aid with location
and cannulation of target vessels during FEVAR.
Methods: In a series of 81 FEVAR procedures, aortic IVUS was ob-
tained during FEVAR. During the ﬁrst 30, routine precannulation of at least
two target vessels was used to aid with proper alignment of the correspond-
ing fenestrations. For the last 51 FEVARs, precannulation was no longer
performed and IVUS was instead used for fenestrated endograft orientation.
The 2  2 table method, kappa statistic, and Bland-Altman analysis were
used to characterize the ability of IVUS to discriminate target vessel location
and clock position conﬁrmed angiographically.
Results: To determine target vessel location, the sensitivity of IVUS
was 95% for the celiac artery, 96% for the superior mesenteric artery, and
90% for the renal arteries. For juxtarenal aneurysms, the sensitivity was
100% for both visceral and renal artery locations, whereas in those with supra-
renal aneurysms, the sensitivity was 98% for the visceral arteries and 90% for
the renal arteries. For paravisceral and thoracoabdominal aortic aneurysms,
IVUS sensitivity was >80% for the celiac artery and SMA, and 60% for the
renal arteries. The accuracy of IVUS to determine clock position of target
vessels was > 90%. In addition to fenestration alignment, the operative tech-
nique for FEVARwas altered based on the ﬁndings of IVUS in 16 procedures
(20%), in which the distal bifurcated component was deployed prior to target
vessels stenting to prevent stent deformity with the tip of the delivery system
given the path of the stiff guidewire used to deliver the endografts.
Conclusions: IVUS is accurate in determining the location of target
vessels during FEVAR and may alter the operative plan in 20% of the proce-
dures. Although IVUS is less reliable for the precise location of visceral and
renal vessels in thoracoabdominal and paravisceral aortic aneurysms, it can
accurately predict target vessel location in most juxta/suprarenal aneurysms,
which may facilitate safe and expeditious FEVAR.
An Expanding Right Popliteal Artery Aneurysm with a Type-II
Geniculate Endoleak 5 Years after Exclusion and Bypass
Marika K. Bergenstocka, Joseph M. Anain Sr.b, Paul M. Anainb. aNew York
College of Osteopathic Medicine, Old Westbury, NY; bSisters of Charity
Hospital, Buffalo, NY
Objectives: Popliteal artery aneurysms (PAAs) are managed by open
bypass graft with ligation (OBGL) or by endovascular (ENDO) repair.
OBGL is the gold standard for PAA repair. Complications of OBGL are
rare; however, reports of continued growth of the excluded PAA, mass
effects, embolization, and rupture have all been described. In this report,
we describe an uncommon presentation of an expanding aneurysm of
a popliteal artery after OBGL.
Methods: A 77-year-old man with a history of a PAA, who previously
had been treated with OBGL, presented 5 years later with leg pain and
a palpable popliteal mass. Physical exam showed patent bypass and full distal
pulses.
Results: Computed tomographic angiogram revealed a large fusiform
PAA, 7  9 cm, with a predominantly thrombosed aneurysm sac with “faint”
contrast (Fig 1). Angiogram revealed a popliteal aneurysm. The original
bypass graft remained patent; however, therewas evidence of graft compression
by the expanding aneurysm at the level of the knee joint. A large, type-II
geniculate endoleak was identiﬁed (Fig 2). Given the angle to the tibial vessel,
endovascular options could not be performed. An open, lateral approach was
used toopen the aneurysmsac.A large amountofmural thrombuswas removed.
There were two small feeding vessels ﬁlling the aneurysm sac that were ligated
from the inside (Fig 3). Further examination of nearby structures revealed
